Sáez J C, Nairn A C, Czernik A J, Spray D C, Hertzberg E L, Greengard P, Bennett M V
Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461.
Eur J Biochem. 1990 Sep 11;192(2):263-73. doi: 10.1111/j.1432-1033.1990.tb19223.x.
Phosphorylation of connexin 32, the major liver gap-junction protein, was studied in purified liver gap junctions and in hepatocytes. In isolated gap junctions, connexin 32 was phosphorylated by cAMP-dependent protein kinase (cAMP-PK), by protein kinase C (PKC) and by Ca2+/calmodulin-dependent protein kinase II (Ca2+/CaM-PK II). Connexin 26 was not phosphorylated by these three protein kinases. Phosphopeptide mapping of connexin 32 demonstrated that cAMP-PK and PKC primarily phosphorylated a seryl residue in a peptide termed peptide 1. PKC also phosphorylated seryl residues in additional peptides. CA2+/CaM-PK II phosphorylated serine and to a lesser extent, threonine, at sites different from those phosphorylated by the other two protein kinases. A synthetic peptide PSRKGSGFGHRL-amine (residues 228-239 based on the deduced amino acid sequence of rat connexin 32) was phosphorylated by cAMP-PK and by PKC, with kinetic properties being similar to those for other physiological substrates phosphorylated by these enzymes. Ca2+/CaM-PK II did not phosphorylate the peptide. Phosphopeptide mapping and amino acid sequencing of the phosphorylated synthetic peptide indicated that Ser233 of connexin 32 was present in peptide 1 and was phosphorylated by cAMP-PK or by PKC. In hepatocytes labeled with [32P]orthophosphoric acid, treatment with forskolin or 20-deoxy-20-oxophorbol 12,13-dibutyrate (PDBt) resulted in increased 32P-incorporation into connexin 32. Phosphopeptide mapping and phosphoamino acid analysis showed that a seryl residue in peptide 1 was most prominently phosphorylated under basal conditions. Treatment with forskolin or PDBt stimulated the phosphorylation of peptide 1. PDBt treatment also increased the phosphorylation of seryl residues in several other peptides. PDBt did not affect the cAMP-PK activity in hepatocytes. It has previously been shown that phorbol ester reduces dye coupling in several cell types, however in rat hepatocytes, dye coupling was not reduced by treatment with PDBt. Thus, activation of PKC may have differential effects on junctional permeability in different cell types; one source of this variability may be differences in the sites of phosphorylation in different gap-junction proteins.
对主要的肝间隙连接蛋白连接蛋白32的磷酸化作用,在纯化的肝间隙连接和肝细胞中进行了研究。在分离的间隙连接中,连接蛋白32可被环磷酸腺苷依赖性蛋白激酶(cAMP-PK)、蛋白激酶C(PKC)以及钙离子/钙调蛋白依赖性蛋白激酶II(Ca2+/钙调蛋白-PK II)磷酸化。连接蛋白26不会被这三种蛋白激酶磷酸化。连接蛋白32的磷酸肽图谱表明,cAMP-PK和PKC主要使一个名为肽段1的肽段中的一个丝氨酸残基磷酸化。PKC还使其他肽段中的丝氨酸残基磷酸化。Ca2+/钙调蛋白-PK II在与其他两种蛋白激酶磷酸化位点不同的位置使丝氨酸磷酸化,苏氨酸磷酸化程度较低。一种合成肽PSRKGSGFGHRL-胺(基于大鼠连接蛋白32推导的氨基酸序列中的第228 - 239位残基)可被cAMP-PK和PKC磷酸化,其动力学特性与这些酶磷酸化的其他生理底物相似。Ca2+/钙调蛋白-PK II不会使该肽段磷酸化。对磷酸化合成肽的磷酸肽图谱分析和氨基酸测序表明,连接蛋白32的Ser233存在于肽段1中,并被cAMP-PK或PKC磷酸化。在用[32P]正磷酸标记的肝细胞中,用福司可林或20 - 脱氧 - 20 - 氧佛波醇12,13 - 二丁酸酯(PDBt)处理导致连接蛋白32中32P掺入增加。磷酸肽图谱分析和磷酸氨基酸分析表明,在基础条件下,肽段1中的一个丝氨酸残基磷酸化最为显著。用福司可林或PDBt处理可刺激肽段1的磷酸化。PDBt处理还增加了其他几个肽段中丝氨酸残基的磷酸化。PDBt不影响肝细胞中的cAMP-PK活性。先前已表明佛波酯可降低几种细胞类型中的染料偶联,然而在大鼠肝细胞中,用PDBt处理并未降低染料偶联。因此,PKC的激活可能对不同细胞类型中的连接通透性有不同影响;这种变异性的一个来源可能是不同间隙连接蛋白中磷酸化位点的差异。